Nisa Investment Advisors, LLC Crispr Therapeutics Ag Transaction History
Nisa Investment Advisors, LLC
- $25.4 Billion
- Q3 2025
A detailed history of Nisa Investment Advisors, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 2,525 shares of CRSP stock, worth $165,943. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,525
Previous 2,212
14.15%
Holding current value
$165,943
Previous $107,000
52.34%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CRSP
# of Institutions
545Shares Held
68.4MCall Options Held
3.67MPut Options Held
2.25M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$669 Million4.09% of portfolio
-
Capital International Investors Los Angeles, CA5.59MShares$368 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.68MShares$242 Million0.11% of portfolio
-
State Street Corp Boston, MA3.27MShares$215 Million0.01% of portfolio
-
Ubs Group Ag2.84MShares$187 Million0.02% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $5.13B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....